3522
G. A. N. Felton, N. L. Bauld / Tetrahedron 61 (2005) 3515–3523
(CIC): 267, 209, 191. HRMS (CIC): calcd; 267.1055,
found; 267.1062.
2 mg (3%) of 3a were isolated, along with 8.4 mg of
recovered 1.
1
Compound 6j. H NMR (300 MHz, CDCl ): partial only:
Electrolysis of 84 mg (0.021 M) of 1 and 142 mg (0.064 M;
3.08:1 ratio relative to 1) of 2m was carried out for 22.2 8C.
Upon extraction/PTLC 16.8 mg (13%) of 3m, 26.1 mg
(15%) of 4m, 19.8 mg (13%) of 7m, and 1.3 mg (2%) of 2a
were isolated.
3
3
.73 (1H, d, JZ2.4 Hz).
4
.12. Electrolysis of 1 with propenyl methyl ketone (2k)
Electrolysis of 100 mg (0.025 M) of 1 and 137 mg,
corrected to 116 mg (0.063 M; 2.52:1 ratio relative to 1)
of 2k was carried out for 12.6 8C. Upon extraction/PTLC
38 mg (26%) of 3k and 4 mg (4%) of impure 3a were
isolated.
1
Compound 3m. H NMR (300 MHz, CDCl
): 1.23 (3H, t,
3
JZ7.2 Hz), 1.89 (3H, d, JZ7.2 Hz), 2.49 (4H, m), 4.09
(2H, q, JZ7.2 Hz), 7.05 (1H, q. JZ7.2 Hz), 7.53 (2H, m),
1
7.63 (1H, m), 7.85 (2H, m). C NMR (500 MHz, CDCl
3
):
4.1, 14.2, 21.4, 32.9, 60.6, 128.1 (2C), 129.2 (2C), 133.2,
3
1
1
Compound 3k. H NMR (300 MHz, CDCl ): 1.01 (3H, d,
138.7, 139.6, 140.5, 172.2. LRMS (CIC): 283. HRMS
(CIC): calcd; 283.1004, found; 283.1004.
3
JZ6.9 Hz), 1.96 (6H, m), 2.68 (2H, m) 3.35 (1H, m), 6.98
(
m)). C NMR (500 MHz, CDCl ): 14.6, 19.0, 28.1, 30.0,
1H, q. JZ7.2 Hz), 7.51 (2H, m), 7.59 (1H, m), 7.83 (2H,
13
1
Compound 4m. H NMR (300 MHz, CDCl
): 1.26 (6H, t,
3
3
4
2
2
8.2, 127.9 (2C), 129.1 (2C), 133.1, 138.7, 140.9, 145.1,
06.3. LRMS (CIC): 267, 125. HRMS (CIC): calcd;
67.1055, found; 267.1051.
JZ7.2 Hz), 2.11 (2H, m), 2.33 (4H, m), 2.63 (2H, m), 4.14
(4H, q, JZ7.2 Hz), 5.09 (1H, d, JZ17.7 Hz), 5.38 (1H, d,
JZ10.8 Hz), 5.75 (1H, dd, JZ10.8, 17.7 Hz), 7.52 (2H, t,
1
3
JZ7.5 Hz), 7.65 (1H, m), 7.80 (2H, d, JZ7.2 Hz).
NMR (500 MHz, CDCl ): 14.2 (2C), 24.8 (2C), 28.7 (2C),
0.8 (2C), 68.9, 121.4, 128.6 (2C), 130.7 (2C), 133.9, 134.8,
C
4
.13. Electrolysis of 1 with methyl acrylate (2l)
3
6
Electrolysis of 85 mg (0.021 M) of 1 and 84 mg (0.044 M;
.09:1 ratio relative to 1) of 2l was carried out for 18.0 8C.
135.1, 172.6 (2C). LRMS (CIC): 383, 241. HRMS (CIC):
calcd; 383.1528, found; 383.1517.
2
Upon extraction/PTLC 22.5 mg (18%) of 3l, 27 mg (16%)
of 4l, 18.1 mg (12%) of 7l and 6.4 mg (8%) of 2a were
isolated.
1
Compound 7m. H NMR (300 MHz, CDCl
): 1.29
(3H-enol, 3H-keto, overlapping t), 2.14–2.51 (4H-enol,
3
6
H-keto, overlapping m), 2.60 (1H-enol, d, JZ16.2 Hz),
1
Compound 3l. H NMR (300 MHz, CDCl ): 1.89 (3H, d,
2.87 (1H-enol, d, JZ15.6 Hz), 4.22 (2H-keto, 2H-enol, m),
5.10 (1H, d, JZ17.4 Hz), 5.44 (1H, d, JZ10.8 Hz), 5.70
(1H, dd, JZ10.8, 17.4 Hz), 7.55 (2H, t, JZ7.8 Hz), 7.67
(1H, t, JZ7.5 Hz), 7.84 (2H, d, JZ7.2 Hz), 12.16 (1H-enol,
3
JZ6.9 Hz), 2.51 (4H, m), 3.65 (3H, s), 7.06 (1H, q. JZ
1
.2 Hz), 7.54 (2H, m), 7.62 (1H, m), 7.85 (2H, m). C NMR
3
7
(
300 MHz, CDCl ): 14.3, 21.7, 32.9, 52.0, 128.3 (2C), 129.5
3
1
3
(2C), 133.5, 139.0, 139.7, 140.5, 172.9. LRMS (CIC): 269.
HRMS (CIC): calcd; 269.0848, found; 269.0851.
s). C NMR (500 MHz, CDCl
60.7, 66.2, 94.3, 122.5, 128.5 (2C), 130.8 (2C), 131.9,
33.9, 135.0, 170.1, 171.7. LRMS (CIC): 337, 195. HRMS
(CIC): calcd; 337.1110, found; 337.1109.
3
): 14.2, 24.3, 25.1, 25.7,
1
1
Compound 4l. H NMR (300 MHz, CDCl ): 2.12 (2H, m),
3
2
1
1
.35 (4H, m), 2.65 (2H, m), 3.69 (6H, s), 5.09 (1H, d, JZ
7.4 Hz), 5.39 (1H, d, JZ10.8 Hz), 5.75 (1H, dd, 10.8, JZ
7.4 Hz), 7.53 (2H, t, JZ7.5 Hz), 7.66 (1H, m), 7.80 (2H,
4
.15. Electrolysis of 1 with phenyl acrylate (2n)
1
3
m). C NMR (300 MHz, CDCl ): 25.0 (2C), 28.7 (2C),
3
Electrolysis of 110 mg (0.027 M) of 1 and 182 mg
0.056 M; 2.03:1 ratio relative to 1) of 2n was carried out
5
1
2.2 (2C), 69.0, 121.7, 128.8 (2C), 130.9 (2C), 132.1, 132.6,
34.9, 173.2 (2C). LRMS (CIC): 355, 213. HRMS (CIC):
(
for 35.0 8C. Upon extraction/PTLC 40.2 mg (22%) of 3n
and 23.9 mg (24%) of 2a were isolated, along with 9 mg of
recovered 1.
calcd; 355.1215, found; 355.1219.
1
Compound 7l. H NMR (300 MHz, CDCl ): 1.92–2.02
3
(
1H-keto, m), 2.15–2.51 (4H-enol, 5H-keto, overlapping
m), 2.57 (1H-enol, d, JZ15.9 Hz), 2.86 (1H-enol, d, JZ
5.3 Hz), 3.67 (3H-keto, s), 3.76 (3H-enol, s), 5.10 (1H, d,
1
Compound 3n. H NMR (300 MHz, CDCl ): 1.94 (3H, d,
JZ7.2 Hz), 2.65 (2H, m), 2.78 (2H, m), 7.05 (2H, d, JZ
3
1
8
.4 Hz), 7.12 (1H, q. JZ6.9 Hz), 7.23 (1H, m), 7.38 (2H, t,
JZ17.4 Hz), 5.44 (1H, d, JZ10.8 Hz), 5.71 (1H, dd, 10.8,
JZ17.4 Hz), 7.55 (2H, t, JZ7.8 Hz), 7.67 (1H, t, JZ
7
(
3
13
JZ7.8 Hz), 7.55 (2H, m), 7.64 (1H, m), 7.90 (2H m). C
NMR (300 MHz, CDCl ): 14.5, 21.5, 32.7, 121.7 (2C),
3
.2 Hz), 7.84 (2H, d, JZ7.8 Hz), 12.08 (1H-enol, s). LRMS
CIC): 323, 181. HRMS (CIC): calcd; 323.0953, found;
23.0943. X-ray crystallography confirms enol structure
CCDC 254677).
1
1
26.1, 126.2, 128.3 (2C), 129.5 (2C), 129.7 (2C), 129.8,
39.4, 140.3, 171.2. LRMS (CIC): 365, 331, 183. HRMS
(CIC): calcd; 331.1004, found; 331.1012.
(
4
.14. Electrolysis of 1 with ethyl acrylate (2m)
4.16. Electrolysis of 1 with methyl crotonate (2o)
Electrolysis of 87 mg (0.022 M) of 1 and 100 mg (0.045 M;
.09:1 ratio relative to 1) of 2m was carried out for 9.2 8C.
Upon extraction/PTLC 34.4 mg (28%) of 3m, 33.6 mg
20%) of 4m, 10 mg (7%) of 7m, 6.6 mg (8%) of 2a and
Electrolysis of 80 mg (0.020 M) of 1 and 88 mg (0.040 M;
2.00:1 ratio relative to 1) of 2o was carried out for 4.0 8C.
Upon extraction/PTLC 8 mg (6%) of 3o and 46 mg (58%) of
3a were isolated.
2
(